These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36421286)

  • 1. Iron Chelator DIBI Suppresses Formation of Ciprofloxacin-Induced Antibiotic Resistance in
    Allan DS; Holbein BE
    Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36421286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Iron-Chelator DIBI Inhibits
    Parquet MDC; Savage KA; Allan DS; Davidson RJ; Holbein BE
    Front Microbiol; 2018; 9():1811. PubMed ID: 30154764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic-Resistant
    Parquet MDC; Savage KA; Allan DS; Ang MTC; Chen W; Logan SM; Holbein BE
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209004
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of antibiotic resistance in Klebsiella pneumoniae exposed to sequential in vitro antibiotic treatments.
    Kim J; Jo A; Chukeatirote E; Ahn J
    Ann Clin Microbiol Antimicrob; 2016 Dec; 15(1):60. PubMed ID: 27938381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron-withdrawing anti-infectives for new host-directed therapies based on iron dependence, the Achilles' heel of antibiotic-resistant microbes.
    Holbein BE; Ang MTC; Allan DS; Chen W; Lehmann C
    Environ Chem Lett; 2021; 19(4):2789-2808. PubMed ID: 33907538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage.
    Greenshields AL; Power Coombs MR; Fernando W; Holbein BE; Hoskin DW
    Biometals; 2019 Dec; 32(6):909-921. PubMed ID: 31624972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Activity of the Iron-Chelator, DIBI, against Multidrug-Resistant Canine Methicillin-Susceptible
    Nocera FP; Iovane G; De Martino L; Holbein BE
    Pathogens; 2022 Jun; 11(6):. PubMed ID: 35745511
    [No Abstract]   [Full Text] [Related]  

  • 8. Iron Sequestrant DIBI, a Potential Alternative for Nares Decolonization of Methicillin-Resistant Staphylococcus aureus, Is Anti-infective and Inhibitory for Mupirocin-Resistant Isolates.
    Allan DS; Parquet MDC; Savage KA; Holbein BE
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics-based discrimination of differentially expressed proteins in antibiotic-sensitive and antibiotic-resistant Salmonella Typhimurium, Klebsiella pneumoniae, and Staphylococcus aureus.
    Uddin MJ; Ma CJ; Kim JC; Ahn J
    Arch Microbiol; 2019 Nov; 201(9):1259-1275. PubMed ID: 31240342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of fluoroquinolone-resistant Staphylococcus aureus: oscillating ciprofloxacin concentrations simulated at the upper and lower portions of the mutant selection window.
    Firsov AA; Lubenko IY; Smirnova MV; Strukova EN; Zinner SH
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1924-8. PubMed ID: 18378704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel iron chelator, DIBI, attenuates inflammation and improves outcome in colon ascendens stent peritonitis-induced experimental sepsis.
    Fokam D; Aali M; Dickson K; Scott C; Holbein B; Zhou J; Lehmann C
    Clin Hemorheol Microcirc; 2020; 76(2):241-261. PubMed ID: 32925011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles
    Savage KA; Parquet MC; Allan DS; Davidson RJ; Holbein BE; Lilly EA; Fidel PL
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844048
    [No Abstract]   [Full Text] [Related]  

  • 13. Associations between resistance phenotype and gene expression in response to serial exposure to oxacillin and ciprofloxacin in Staphylococcus aureus.
    Uddin MJ; Ahn J
    Lett Appl Microbiol; 2017 Dec; 65(6):462-468. PubMed ID: 28977678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effects of a novel iron chelator, DIBI, in experimental sepsis.
    Thorburn T; Aali M; Kostek L; LeTourneau-Paci C; Colp P; Zhou J; Holbein B; Hoskin D; Lehmann C
    Clin Hemorheol Microcirc; 2017; 67(3-4):241-250. PubMed ID: 28869457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory and anti-bacterial effects of iron chelation in experimental sepsis.
    Islam S; Jarosch S; Zhou J; Parquet Mdel C; Toguri JT; Colp P; Holbein BE; Lehmann C
    J Surg Res; 2016 Jan; 200(1):266-73. PubMed ID: 26235905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plantaricin A reverses resistance to ciprofloxacin of multidrug-resistant Staphylococcus aureus by inhibiting efflux pumps.
    Meng F; Nie T; Lyu Y; Lyu F; Bie X; Lu Y; Zhao M; Lu Z
    Environ Microbiol; 2022 Oct; 24(10):4818-4833. PubMed ID: 36254863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Inflammatory Effects of the Iron Chelator, DIBI, in Experimental Acute Lung Injury.
    Lehmann C; Alizadeh-Tabrizi N; Hall S; Faridi S; Euodia I; Holbein B; Zhou J; Chappe V
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin-eluting nanofibers inhibits biofilm formation by Pseudomonas aeruginosa and a methicillin-resistant Staphylococcus aureus.
    Ahire JJ; Neveling DP; Hattingh M; Dicks LM
    PLoS One; 2015; 10(4):e0123648. PubMed ID: 25853255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DIBI, a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity.
    Ang MTC; Gumbau-Brisa R; Allan DS; McDonald R; Ferguson MJ; Holbein BE; Bierenstiel M
    Medchemcomm; 2018 Jul; 9(7):1206-1212. PubMed ID: 30109009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes.
    O'Regan E; Quinn T; Frye JG; Pagès JM; Porwollik S; Fedorka-Cray PJ; McClelland M; Fanning S
    Antimicrob Agents Chemother; 2010 Jan; 54(1):367-74. PubMed ID: 19917752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.